<DOC>
	<DOC>NCT01758172</DOC>
	<brief_summary>From postoperative patients having undergone pancreaticoduodenectomy; 1. To compare the hemodynamic parameters from the patient administrated 5% HA and 6% Voluven 2. To assess the efficacy of the treatment as regards the clinical outcomes and laboratory parameters of the patient 3. To compare the safety of the 2 intravenous colloids in the patient population</brief_summary>
	<brief_title>Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Subjects should be meet inclusion criteria to participated into the study 1. Agefrom 1875 years adult 2. In the immediate postoperative period of pancreaticoduodenectomy 3. Written informed consent and admitted ICU immediate postoperative patient Any patient meeting one or more of the following exclusion criteria may not be entered into the study. 1. Refusal to participate in the study 2. Evidence of preoperative oliguria (Serum creatinine&gt;1.5mmol/dL) 3. Known Severe congestive heart failure (NYHAIII,IV) 4. Known severe respiratory diseases (PaO2/FiO2 &lt;200) 5. Known coagulopathy (Platelet&lt;100k/mm3, aPTT&gt;70s, PT(INR)&gt;2.5) 6. Known allergy to hydroxyethyl starch 7. Known pregnancy or lactation 8. Has participated in any other clinical trial within 3months 9. Any contraindication to VoluvenÂ® or albumin according to their package inserts.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>pancreaticoduodenectomy</keyword>
	<keyword>postoperative patient</keyword>
	<keyword>colloid</keyword>
	<keyword>albumin</keyword>
	<keyword>hetastarch</keyword>
</DOC>